Drawing for TWINSTRAND

USPTO serial 97357340

TWINSTRAND

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
POLLACK, ALISON FRIEDBERG
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TWINSTRAND?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Monica Riva Talley

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C1101 K Street, N.W.10th FloorWASHINGTON, DC 20005

Goods and services

ClassDescriptionStatusFirst use
001Kits comprising primarily of reagents, enzymes and nucleotides for forensic research; diagnostic reagents for clinical laboratory useACTIVE—
005medical diagnostic reagents; clinical diagnostic reagents for medical purposes; diagnostic kits consisting primarily of enzymes, nucleic acids, buffers, reagents and assays for use in disease testing for medical purposes; medical diagnostic assays for medical and diagnostic purposes; medical diagnostic reagents and assays for testing body fluids; enzyme preparations for medical purposes; biological preparations for the detection, diagnosis and monitoring of cancer; preparations for detecting genetic predispositions for medical purposesACTIVE—
042genome sequencing and analysis services for forensic science purposes; providing temporary use of non-downloadable computer software for nucleic acid sequencing and genotyping in the fields of medical diagnostics, molecular diagnostics, forensics, and consumer genomicsACTIVE—
044Medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes; consulting and testing services in the field of genetic sequencing for medical, diagnostic and treatment purposes; providing medical genomics testing and reporting services in the field of biomarkers for the susceptibility, risk, diagnosis, prognosis, treatment or management of cancer and other diseases; providing a website featuring medical information regarding genetics for educational purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 22, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 22, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 19, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 18, 2025EX5GSOU EXTENSION 5 GRANTED—
Nov 17, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 16, 2025EXT5SOU EXTENSION 5 FILED—
May 17, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 17, 2025EX4GSOU EXTENSION 4 GRANTED—
May 16, 2025EXT4SOU EXTENSION 4 FILED—
May 16, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 11, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 11, 2025EX3GSOU EXTENSION 3 GRANTED—
Feb 10, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 18, 2024EXT3SOU EXTENSION 3 FILED—
Nov 18, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 16, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 15, 2024EX2GSOU EXTENSION 2 GRANTED—
May 15, 2024EXT2SOU EXTENSION 2 FILED—
May 15, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 31, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 27, 2023EX1GSOU EXTENSION 1 GRANTED—
Oct 27, 2023EXT1SOU EXTENSION 1 FILED—
Oct 27, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 16, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 21, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 21, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 1, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 15, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 15, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Feb 15, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 15, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 15, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 12, 2022GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 12, 2022GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 12, 2022CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 6, 2022DOCKASSIGNED TO EXAMINER—
Apr 15, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 14, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance